Welcome. If you're a registered user, please log-in. If not, please sign-up.
  • registrations@informa-ls.com
  • phone:+44(0)20 7017 7481
  • GO

Sucessfully Implementing PAT and QbD

Discover how to reduce your production life cycle times by up to 40% by implementing PAT/QbD

Informa Life Sciences are delighted to announce our upcoming Successfully Implementing PAT and QbD conference taking place on Wednesday 15 - Thursday 16 September 2010 in the NH Jolly St Ermins, London, UK.

The pharmaceutical industry is now investing more heavily in PAT and working towards full implementation and QbD. However, there seems to be little clarity on how to practically implement the concepts of PAT and its relationship to QbD. Industry are still facing technical and organisational difficulties in applying these tools and strategies. Our conference will provide a practical look at how to implement PAT and QbD in the pharmaceutical and biotech industry – it will be a case study focused programme – outlining examples of real successes and failures of PAT applications. Delegates will learn how to improve process understanding and control, and how this will lead to the promised benefits and ROI of PAT and QbD.

Homepage speakers

Homepage speakers

Jacques Wiss Head of the Chemical and Analytical Development (CHAD) PAT Network Novartis Pharma AG, Switzerland

Wassim Nashabeh Sr Director, Pharma Technical Regulatory Policy & Strategy Genentech, Inc., USA

Doriano Cingolani MTS Lab Manager MERCK SERONO S.A. - Corsier-sur-Vevey, Switzerland

Cristina Oliveira Analytical Scientist, Stability and Validation BIAL - Portela & Co, S.A., Portugal


..

Media Partners

..
..
..
..

This Conference is CPD Certified

..
..
..

Pre-Conference Workshop: Tuesday 14 September 2010

Applying QbD Principles - From Development, Registration and Beyond - A Case Study Example

The workshop is meant to give not only an introduction into Quality by Design, but also an integrated picture of its application throughout a product’s lifecycle. The format chosen is that of a case study, artificially synthesized from real life examples to demonstrate how the following elements may interlink: control strategy, criticality, CTD, design space, PAT, Design of Experiments, pharmaceutical development, real time release, regulatory flexibility, risk management and target product profile.

Evening Seminar: Wednesday 15 September 2010

Evening Seminar: Use of Statistical Process Control (SPC) in a Pharmaceutical Environment
As ICH Q10 Guideline for a Pharmaceutical Quality System gains momentum within the industry, this seminar will introduce how SPC can address terms such as variability, capability, process, understanding and continuous improvement. The seminar will involve getting to grips with the basic concepts of statistical process control and will show case studies from the pharmaceutical industry.
Workshop Leader:
Tom Cochrane, Business Process Development Manager, Napp Pharmaceuticals, UK

 

Who Should Attend?

Who can I expect to meet?
This leading industry forum is aimed at Directors, Heads of Department, Team Leaders and Scientists working in the areas of:
• Research and Development • PAT • Compliance
• Process Development & Optimisation • Manufacturing • Formulation
• Quality Assurance/Quality Control • Operations • Regulatory Affairs
• Engineering • Process Science • Process Analytics

Previous Attendees Include:

Medicines and Medical Devices Agency of Serbia Sanofi Avenits UCB Celltech Ferring Pharmaceuticals Merck SL BRISTOL MYERS SQUIBB   National Institute of Pharmacy LEK Pharmaceutical d d LEO Pharma AS   Merck Serono Serono Biotech Center
National Institute of Pharmacy Elan Corporation Sanofi Avenits Merck Serono SA Boehringer Ingelheim Pharma GmbH & Co K G   AstraZeneca Takeda Pharmaceutical Company Ltd Grunenthal GmbH   Pricewaterhousecoopers Enterprise Advisory Novo Nordisk A/S
Helsinn Birex Pharmaceutical Ltd BRISTOL MYERS SQUIBB   Sanofi Pasteur Industria Farmaceutica Serono LEO Pharma AS Synthon BV Bial - Portela & Ca. S.A Daiichi Sankyo Co Ltd

Dates and Venues

15 Sep 2010 - 16 Sep 2010

NH Jolly St Ermins

Hear what delegates had this to say about our 2009 conference:

"Great diversity; regulatory, scientific, financial, chemical, pharmaceutical. A complete overview of QbD/PAT"
Janssen Pharmaceutical
2009 Delegate
"This conference gave an essential overview of QbD and PAT tools from API derivation to manufacturing of DP and the implementation in various companies"
F. Hoffmann-La Roche Ltd
2009 Delegate
"Very useful, informative and will help further information gathering in this area"
Medicines and Medical Device Agency of Serbia
2009 Delegate

Bookmark and Share